Related Experiment Video
Updated: Jul 19, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation
Eric N Olson1, Johannes Backs, Timothy A McKinsey
1Myogen, Inc., 757 W. 103rd Ave., Westminster, CO 80021, USA.
Insights
Histone deacetylases (HDACs) control pathological cardiac growth. Disrupting HDACs in mice caused enlarged hearts, highlighting HDACs as therapeutic targets for heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Gene Regulation
Background:
- Adult heart remodels under stress, leading to hypertrophy, failure, and death.
- Pathological cardiac remodeling involves reactivation of fetal gene programs, impairing function.
- Histone deacetylases (HDACs) are implicated in controlling pathological cardiac growth.
Purpose of the Study:
- Investigate the role of Class II HDACs in cardiac response to stress.
- Determine the impact of HDAC function on pathological cardiac remodeling and gene expression.
- Explore therapeutic strategies targeting HDACs for heart failure.
Main Methods:
- Utilized HDAC knockout mouse models.
- Analyzed cardiac response to various pathological stress stimuli.
- Examined gene expression related to cardiac growth and MEF2 signaling.
Main Results:
- HDAC knockout mice exhibited hypersensitivity to stress signaling.
- These mice developed significantly enlarged hearts under pathological stress.
- Inability to counteract pathological MEF2 signaling was observed in knockout mice.
Conclusions:
- Class II HDACs are crucial for maintaining normal cardiac size and function.
- Dysregulation of HDACs promotes pathological cardiac hypertrophy and failure.
- Modulating HDAC phosphorylation and function offers a potential therapeutic avenue for heart failure.
Abstract:
The adult heart responds to acute and chronic stresses by a remodelling process that is accompanied by myocyte hypertrophy, impaired contractility, and pump failure, often culminating in sudden death. Pathological growth and remodelling of the adult heart is often associated with the reactivation of a fetal cardiac gene program that further weakens cardiac performance. Recent studies have revealed key roles for histone deacetylases (HDACs) in the control of pathological cardiac growth. Class II HDACs associate with the MEF2 transcription factor, and other factors, to maintain normal cardiac size and function. Stress signals lead to the phosphorylation of class II HDACs and their export from the nucleus to the cytoplasm, with consequent activation of genes involved in cardiac growth. HDAC knockout mice are hypersensitive to stress signalling and develop massively enlarged hearts in response to various pathological stress stimuli due to an inability to counteract pathological signalling to MEF2. Strategies for normalizing gene expression in the failing heart by regulating HDAC phosphorylation and function represent potentially powerful therapeutic approaches.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy III: Hypertrophic Cardiomyopathy

